Rick Wurster, president and CEO of @CharlesSchwab, joins The Watch List to discuss the company's latest earnings and what's ahead for clients. He talks about why Charles Schwab takes "no tradeoffs" for investors and explains how he balances client satisfaction with earnings growth.

Banco Santander, S.A. (SAN) Q4 2025 Earnings Call Prepared Remarks Transcript

Broadridge Financial Solutions, Inc. has continued to report healthy financial momentum. Recurring revenues once again grew well in Q2. Financial momentum has been overshadowed by a major concern. BR's positioning as an intermediary is on uncertain grounds if capital markets move towards tokenization. BR is proactively investing in tokenization, but attracting DLR volume and generating a similar level of revenues isn't certain.

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Ramaco Resources, Inc. (NASDAQ: METC).

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CORCEPT THERAPEUTICS INCORPORATED (CORT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER.

Easterly Government Properties is upgraded to Buy, driven by new portfolio growth, high occupancy, and a compelling 7.8% dividend yield. DEA benefits from long-term leases with federal agencies, 97% occupancy, and geographic diversification, supporting predictable cash flows despite federal budget uncertainties. DEA trades at a significant valuation discount to peers, with strong EBITDA margins and a proven dividend growth record, though historic AFFO growth lags sector averages.

Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.

Houlihan Lokey's restructuring revenues have been subject to timing effects, which will penalise their performance relative to peers in Q4. In general, we've seen better Investment Banking performances from some other mid-market picks. Large-ticket picks in general and select mid-market peers, especially PIPR, offer better value and earnings momentum than HLI in the current environment.

Although former Berkshire Hathaway (NYSE:BRK-B) CEO Warren Buffett retired as the company's chief executive, his legacy looms large.

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of all persons or entities who purchased or otherwise acquired BlackRock TCP Capital Corp. (“BlackRock” or the “Company”) (NASDAQ: TCPC) securities between November 6, 2024 and January 23, 2026, inclusive (the “Class Period”).

Both Novo Nordisk and Eli Lilly are grappling with pricing pressure in the U.S., but their 2026 outlooks are diverging sharply. While Novo is bracing for a sales decline, Lilly sees revenue charging ahead thanks to its blockbuster medicines.

Fortive Corporation (FTV) Q4 2025 Earnings Call Transcript

RenaissanceRe beats Q4 earnings as lower claims costs and strong investment results drive underwriting income higher despite weaker premiums.

NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Coupang, Inc. ("Coupang, Inc." or the "Company") (NYSE: CPNG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Coupang, Inc. investors who were adversely affected by alleged securities fraud between May 7, 2025 and December 16, 2025.

NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Vistagen Therapeutics, Inc. ("Vistagen" or the "Company") (NASDAQ: VTGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Vistagen investors who were adversely affected by alleged securities fraud between April 1, 2024 and December 16, 2025.

NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in BellRing Brands, Inc. ("BellRing Brands, Inc." or the "Company") (NYSE: BRBR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BellRing Brands, Inc. investors who were adversely affected by alleged securities fraud between November 19, 2024 and August 4, 2025.

NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Bath & Body Works, Inc. ("Bath & Body Works, Inc." or the "Company") (NYSE: BBWI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Bath & Body Works, Inc. investors who were adversely affected by alleged securities fraud between June 4, 2024 and November 9, 2025.

NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc.

NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Beyond Meat, Inc. ("Beyond Meat, Inc." or the "Company") (NASDAQ: BYND) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Beyond Meat, Inc. investors who were adversely affected by alleged securities fraud between February 27, 2025 and November 11, 2025.

NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in CoreWeave, Inc. ("CoreWeave, Inc." or the "Company") (NASDAQ: CRWV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of CoreWeave, Inc. investors who were adversely affected by alleged securities fraud between March 28, 2025 and December 15, 2025.